Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
DOUG Doug Elliman posts deeperthanexpected loss despite revenue growth shares fall 33 MYPSW PLAYSTUDIOS management teases new loyalty program launches ahead of upcoming quarterly earnings release Is KLX Energy KLXE stock hiding in plain sight Momentum Fading 20260506 Why Capital One COF might be the portfolio Builder you need Market Focus 20260503 From Boxcars to a BillionDollar Network The Rise of a Logistics Powerhouse Anchorage CPI Report Released for April 2026 Inflation Trends Under Review Security Incident Near White House May Spotlight Government Safety Protocols SEC Advances Proposal to End Mandatory Quarterly Earnings Reports Backed by Trump Microsoft in Talks to Supply Custom AI Chips to Anthropic Following 5 Billion Investment Comex Gold Silver Settle Lower as Precious Metals Pull Back PSNYW Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Challenges for Polestar ARRY Q1 2026 Earnings Earnings Surge Past Estimates Despite Revenue Uncertainty AMPL Q1 2026 Earnings EPS Misses Estimates as Shares Rise Despite Challenging Quarter CNMD Q1 2026 Earnings EPS Surprise Fails to Lift Stock as Revenue Picture Stays Cloudy FTNT Q1 2026 Earnings EPS Surges 30 Above Estimates CODI Q1 2026 Earnings Stunning EPS Beat Masks Broader Market Concerns Leidos Holdings LDOS Posts 192 Gain Approaches Resistance Zone InterDigital IDCC Edges Higher as Patent Licensing Stock Holds Key Support Artius II Acquisition Rights AACBR Hold Steady at 025 as Traders Watch Key Levels Assembly Biosciences ASMB Declines 47 as Stock Tests Key Support Near 26 GD Culture Group Limited GDC Bounces 10 from Support Faces Key Resistance at 013 BRC Inc BRCC Edges Lower as Stock Holds Near Key Support Level Thermon Group Holdings THR Surges 765 on Strong Volume Tests Key Resistance Definium Therapeutics DFTX Gains on Strength Approaching Key Resistance BDCIW Holds Steady at 045 as Trading Range Consolidates Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone Rezolve AI Warrants RZLVW Edge Higher Amid Low Volume Key Levels to Watch